Views on the Introduction of Medical Male Circumcision for HIV Prevention in South Africa
May 21, 2012
The partial efficacy (40 percent to 60 percent) of surgically conducted medical male circumcision (MMC) in preventing HIV transmission to circumcised men has been demonstrated in three clinical trials. "This research formed part of a larger study exploring the importance of integration of sexual and reproductive health with HIV services," the authors wrote, noting the objective of eliciting key informants' views on the introduction of MMC for HIV prevention in South Africa.
04.2012; Vol. 24; No. 4: P. 496-501; Cecilia Milford; and others
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)